LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.
June 16, 2021 (LifeSiteNews) — Dr. Pierre Kory, the chief medical officer of the Front Line COVID-19 Critical Care (FLCCC) Alliance, called the U.S. government’s decision to grant $1.2 billion to develop a drug to combat COVID-19 a “colossal waste of taxpayer money for a drug we don’t need,” especially since ivermectin works so well.
This month, the U.S. government agreed to give $1.2 billion of taxpayer money to the pharmaceutical drug company Merck to develop molnupiravir, a drug to combat COVID-19 symptoms.
Kory publicly condemned the decision, arguing that this is a waste of funds considering that already available drugs have been proved to cure patients suffering from COVID-19.
Established in 2020, the FLCCC Alliance has been actively researching and developing “lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.”
Kory revealed that the U.S. government is “going to commit $1.2 billion of taxpayer money in order to enrich Merck for a drug that is not yet available, which has already been the source of a whistleblower complaint, and which has already failed in hospitalized patients.”
— Article continues below Petition —
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
